NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. 2008

P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
Department of Environmental Toxicology, The Institute of Environmental and Human Health, Texas Tech University, Lubbock, TX, USA.

The efficacy of NovaSil clay (NS) to reduce aflatoxin (AF) biomarkers of exposure was evaluated in 656 blood samples and 624 urine samples collected from study participants during a 3-month phase IIa clinical intervention trial in Ghana. NS was delivered before meals via capsules. Serum AFB (1)-albumin adduct was measured by radioimmunoassay and urinary AFM (1) metabolites were quantified by immunoaffinity-high-performance liquid chromatography (HPLC)-fluorescence methods. Levels of AFB (1) -albumin adduct in serum samples collected at baseline and at 1 month were similar (p = 0.2354 and p = 0.3645, respectively) among the placebo (PL), low dose (LD, 1.5 g NS day (-1)), and high dose (HD, 3.0 g NS day (-1)) groups. However, the levels of AFB (1)-albumin adduct at 3 months were significantly decreased in both the LD group (p < 0.0001) and the HD group (p < 0.0001) compared with levels in the PL group. Levels of AFM(1) in urine samples collected at baseline and at 1 month were not statistically different among the three study groups. However, a significant decrease (up to 58%) in the median level of AFM (1) in samples collected at 3 months was found in the HD group when compared with the median level in the PL group (p < 0.0391). In addition, significant effects were found for dose, time, and dose-time interaction with serum AFB(1)-albumin adduct and dose-time interaction with urinary AFM (1) metabolites. The results suggest that capsules containing NS clay can be used to reduce effectively the bioavailability of dietary AF based on a reduction of AF-specific biomarkers.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005503 Food Additives Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. Additive, Food,Additives, Food,Food Additive
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077215 Clay A naturally-occurring rock or soil constituent characterized by particles with a diameter of less than 0.005 mm. It is composed primarily of hydrous aluminum silicates, trace amounts of metal OXIDES, and organic matter. Halloysite,Clays,Halloysites
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000348 Aflatoxins Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2. Aflatoxin

Related Publications

P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
December 2011, Applied clay science,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
February 2008, Carcinogenesis,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
December 2008, Tropical animal health and production,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
May 2019, Drug and chemical toxicology,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
September 2013, Toxins,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
July 2021, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
January 2022, Global pediatric health,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
March 1982, Mycopathologia,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
December 2001, Proceedings of the National Academy of Sciences of the United States of America,
P Wang, and E Afriyie-Gyawu, and Y Tang, and N M Johnson, and L Xu, and L Tang, and H J Huebner, and N-A Ankrah, and D Ofori-Adjei, and W Ellis, and P E Jolly, and J H Williams, and J-S Wang, and T D Phillips
June 2009, Mycotoxin research,
Copied contents to your clipboard!